Form 10-Q · Quarterly report
NVR, Inc. 10-Q, filed Aug 5, 2026
- Filed
- CIK
- 0000906163
- Accession no.
- 0000906163-26-000093
Summary
NVR, Inc.'s second-quarter 2026 consolidated revenues declined 10% year over year to $2.326 billion, while net income fell 29% to $236.5 million and homebuilding gross margin narrowed to 19.2% from 21.5%. New orders rose 9% and the cancellation rate fell to 14.9%, though management said affordability issues, high home inventory, weak consumer sentiment and economic volatility continued to weigh on demand and home prices.
Key points
- NVR's second-quarter 2026 revenues were $2,326,356 thousand, a 10% decrease from the second quarter of 2025.
- Net income for the quarter was $236,458 thousand, or $83.96 per diluted share, down 29% and 23% respectively from a year earlier.
- Homebuilding gross profit margin was 19.2%, down from 21.5%; new orders increased 9%, and the cancellation rate decreased to 14.9% from 16.5%.
- As of June 30, 2026, NVR controlled approximately 184,400 lots, including about 174,900 under lot purchase agreements, and had four joint ventures expected to produce about 8,000 lots.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations (dollars in thousands, except per share data) Forward-Looking Statements Some of the statements in this Quarterly Report on Form 10-Q, as well as statements made by us in periodic press releases or other public communications, constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.